Efficacy, safety, and resistance profile of osimertinib in T790M mutation-positive non-small cell lung cancer in real-world practice

The efficacy and safety of osimertinib were demonstrated in clinical trials; however, real-world clinical data, particularly the resistance profile, are limited. Here, we investigated the efficacy, safety, and resistance profile of osimertinib in real-world practice. We reviewed medical records of T...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Dong Kyu, Ji, Won Jun, Kim, Woo Sung, Choi, Chang-Min, Yoon, Shin-Kyo, Rho, Jin Kyung, Lee, Jae Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326493/
https://www.ncbi.nlm.nih.gov/pubmed/30625213
http://dx.doi.org/10.1371/journal.pone.0210225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326493/
https://www.ncbi.nlm.nih.gov/pubmed/30625213
http://dx.doi.org/10.1371/journal.pone.0210225

Ejemplares similares